Ayurcann Holdings Corp.
AYURF
$0.0182
-$0.0006-3.19%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.27M | 5.36M | 6.09M | 4.66M | 4.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.27M | 5.36M | 6.09M | 4.66M | 4.81M |
| Cost of Revenue | 3.47M | 3.02M | 3.76M | 3.82M | 3.01M |
| Gross Profit | 1.80M | 2.34M | 2.33M | 843.10K | 1.80M |
| SG&A Expenses | 1.95M | 2.12M | 2.29M | 2.41M | 1.83M |
| Depreciation & Amortization | 118.60K | 151.80K | 145.70K | 119.10K | 131.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.54M | 5.30M | 6.19M | 6.35M | 4.97M |
| Operating Income | -269.50K | 64.20K | -102.20K | -1.68M | -160.80K |
| Income Before Tax | -391.40K | -87.00K | -261.50K | -1.95M | -192.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -391.40K | -87.00K | -261.50K | -1.95M | -192.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -391.40K | -87.00K | -261.50K | -1.95M | -192.90K |
| EBIT | -269.50K | 64.20K | -102.20K | -1.68M | -160.80K |
| EBITDA | -144.70K | 227.10K | 49.00K | -1.48M | 65.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 194.70M | 194.70M | 194.70M | 194.58M | 192.33M |
| Average Diluted Shares Outstanding | 194.70M | 194.70M | 194.70M | 194.58M | 192.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |